![myoscience logo](/news-release/logo/296583/0/296583.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A50&size=2)
Bill Brodie Joins myoscience as Vice President of Global Sales and Marketing
February 27, 2013 08:00 ET
|
myoscience
REDWOOD CITY, Calif., Feb. 27, 2013 (GLOBE NEWSWIRE) -- myoscience, inc. is pleased to announce the addition of Bill Brodie to the team as VP, Global Sales and Marketing. Bill was most recently the...
![myoscience logo](/news-release/logo/296583/0/296583.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A50&size=2)
The World's First Toxin Free Dynamic Wrinkle Treatment is Approved in Europe
February 01, 2013 02:00 ET
|
myoscience
IMCAS, Paris, Feb. 1, 2013 (GLOBE NEWSWIRE) -- myoscience, inc. has announced the release of iovera following CE mark approval on 24 January 2013. IMCAS marks the launch of the iovera brand to medical...
![myoscience logo](/news-release/logo/296583/0/296583.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A50&size=2)
myoscience to Present at 2012 Canaccord Genuity Medical Technology Forum
November 27, 2012 07:00 ET
|
myoscience
REDWOOD CITY, Calif., Nov. 27, 2012 (GLOBE NEWSWIRE) -- myoscience, inc., the developer of Focused Cold Therapy for the treatment of peripheral nerve conditions, announced that President & CEO,...
![myoscience logo](/news-release/logo/296583/0/296583.jpg?lastModified=12%2F09%2F2016%2022%3A56%3A50&size=2)
Next Generation of myoscience Device Receives FDA Clearance for Pain Management
July 10, 2012 08:00 ET
|
myoscience
REDWOOD CITY, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- The newest generation of myoscience's novel device technology has received FDA clearance for the treatment of pain.
myoscience's patented...